CY1106633T1 - Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c - Google Patents

Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c

Info

Publication number
CY1106633T1
CY1106633T1 CY20071100726T CY071100726T CY1106633T1 CY 1106633 T1 CY1106633 T1 CY 1106633T1 CY 20071100726 T CY20071100726 T CY 20071100726T CY 071100726 T CY071100726 T CY 071100726T CY 1106633 T1 CY1106633 T1 CY 1106633T1
Authority
CY
Cyprus
Prior art keywords
vitamin
salicylic acid
pharmaceutical compositions
compositions containing
containing copper
Prior art date
Application number
CY20071100726T
Other languages
English (en)
Inventor
John Carter
Original Assignee
John Carter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923431.2A external-priority patent/GB9923431D0/en
Priority claimed from GB0014420A external-priority patent/GB0014420D0/en
Application filed by John Carter filed Critical John Carter
Publication of CY1106633T1 publication Critical patent/CY1106633T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια σύνθεση η οποία περιλαμβάνει: (a) φυσιολογικώς αποδεκτή πηγή αφομοιώσιμου χαλκού. (b) μια πηγή σαλικυλικού οξέος ή ενός φυσιολογικώς αποδεκτού παραγώγου αυτού. και (c) βιταμίνη C.
CY20071100726T 1999-10-04 2007-05-31 Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c CY1106633T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9923431.2A GB9923431D0 (en) 1999-10-04 1999-10-04 Pharmaceutical compositions and their use
GB0014420A GB0014420D0 (en) 2000-06-13 2000-06-13 Pharmaceutical compositions and their use
PCT/GB2000/003770 WO2001024803A2 (en) 1999-10-04 2000-10-02 Pharmaceutical compositions containing copper, salicylic acid and vitamines c

Publications (1)

Publication Number Publication Date
CY1106633T1 true CY1106633T1 (el) 2012-01-25

Family

ID=26244470

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100726T CY1106633T1 (el) 1999-10-04 2007-05-31 Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c

Country Status (13)

Country Link
US (2) US7939109B1 (el)
EP (1) EP1220678B1 (el)
JP (1) JP2003510363A (el)
AT (1) ATE355846T1 (el)
AU (1) AU776732B2 (el)
CA (1) CA2386423C (el)
CY (1) CY1106633T1 (el)
DE (1) DE60033830T2 (el)
DK (1) DK1220678T3 (el)
ES (1) ES2283318T3 (el)
GB (1) GB2356347B (el)
PT (1) PT1220678E (el)
WO (1) WO2001024803A2 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2374008B (en) * 2001-04-04 2005-03-16 John Carter Pharmaceutical compositions comprising copper and zinc
JP2004277379A (ja) * 2003-03-18 2004-10-07 Medicos Hirata:Kk 細胞死誘発ドラッグデリバリーシステム
WO2006110119A1 (fr) * 2005-04-15 2006-10-19 Victor Pavlovich Kutnyak Produit antineoplasique (et variantes)
DE102005020327A1 (de) 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102006001213A1 (de) * 2006-01-10 2007-07-12 Multibind Biotec Gmbh Synergistische Lösung aus Ascobinsäure oder deren Derivaten und Metallionen effizienten, selektiven Abtötung pathologischer Säugerzellen
AU2008239966C1 (en) * 2007-04-13 2012-03-29 Dong Wha Pharmaceutical Co., Ltd. Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
DK178786B1 (en) * 2015-03-11 2017-02-06 Dantrace-Danfeed Ivs Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus
DK178709B1 (en) * 2015-06-17 2016-11-28 Dantrace APPLICATION OF ZINC AND COPPER GLUCONATES IN THE TREATMENT OF DIGITAL DERMATITIS

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415740C2 (de) * 1974-04-01 1983-12-01 Servomed Arznei GmbH & Co Pharma KG, 8000 München Verwendung von Orotsäure bei der analgetischen Behandlung mit Dextropropoxyphen, Natriumsalicylat oder Metamizol
DE2457524A1 (de) * 1974-12-05 1976-06-10 Nadrol Chemie Pharma Keizer Kg Arzneimittel zur beeinflussung des zinkspiegels im mechanismus des zellstoffwechsels
GB2022998B (en) * 1978-06-14 1982-09-08 Beres J Phermaceutical composition for the treatment of neoplasticand other diseases
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
WO1984004922A1 (en) * 1983-06-10 1984-12-20 Int Copper Ass Inc Copper complex for treating cancer
US4853377A (en) * 1985-10-15 1989-08-01 Pollack Robert L Method and composition for increasing production of serotonin
EP0316408A1 (en) * 1987-05-11 1989-05-24 Procyte Corporation Method of tumor inhibition in warm-blooded animals
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
IT8947616A0 (it) * 1989-02-06 1989-02-06 Verde Giancarlo Umberto Preparato per il trattamento e la cura delle emorroidi
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
FR2675996B1 (fr) * 1991-04-30 1993-10-15 Georges Baritiu Compositions sanogenes dietetiques complexes.
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
US5639787A (en) * 1995-02-28 1997-06-17 The Center For The Improvement Of Human Functioning Int'l, Inc. Therapeutic method for the treatment of cancer
CA2233015A1 (en) * 1995-09-25 1997-04-03 Samir Chachoua Therapeutic applications using horse serum
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5897891A (en) 1996-11-18 1999-04-27 Godfrey; John C. Flavorful zinc compositions for oral use incorporating copper
US5770215A (en) 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
US6428580B2 (en) * 1997-08-20 2002-08-06 L'oreal Use of ascorbic acid in permanent waving and hair coloring compositions
US6316008B1 (en) 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
DE19855426A1 (de) 1998-12-02 2000-06-08 Wolfgang Langhoff Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen

Also Published As

Publication number Publication date
ES2283318T3 (es) 2007-11-01
US7758899B2 (en) 2010-07-20
US20050123623A1 (en) 2005-06-09
WO2001024803A3 (en) 2001-08-23
EP1220678A2 (en) 2002-07-10
CA2386423C (en) 2009-07-21
US7939109B1 (en) 2011-05-10
PT1220678E (pt) 2007-06-11
GB2356347B (en) 2002-05-15
WO2001024803A2 (en) 2001-04-12
GB2356347A (en) 2001-05-23
JP2003510363A (ja) 2003-03-18
EP1220678B1 (en) 2007-03-07
DE60033830D1 (de) 2007-04-19
GB0024057D0 (en) 2000-11-15
ATE355846T1 (de) 2007-03-15
DE60033830T2 (de) 2007-11-15
DK1220678T3 (da) 2007-07-09
AU7540300A (en) 2001-05-10
AU776732B2 (en) 2004-09-23
CA2386423A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
CY1106633T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
FI964583A0 (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
SE9904505D0 (sv) Novel compounds
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
RS49673B (sr) Inhibitori sintaze azot-monoksida
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
DK1200418T3 (da) Nematodicide trifluorbutener
NO963673L (no) Orale vehikkelblandinger
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
CY1105112T1 (el) Διαμορφωσεις δια καταπολεμησιν ανθρωπινων φθειρων, πepιεχουσαι σπινοσυνη (spinosyn)
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CY1105387T1 (el) Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
DE69819539D1 (de) Antithrombotische mittel
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TR199802424T2 (xx) Biyo-temin-edilebilirli�i artt�r�lm�� mantara-kar�� bile�im.
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.